NCT04640207 is a NA clinical trial of Facial skin treatment in Rejuvenation, sponsored by Alma Lasers.

Who is sponsoring NCT04640207?

NCT04640207 is sponsored by Alma Lasers.

What drugs are being tested in NCT04640207?

Interventions in NCT04640207: Facial skin treatment.

What condition does NCT04640207 study?

NCT04640207 studies Rejuvenation.

Is NCT04640207 still recruiting?

NCT04640207 is currently completed. Last updated 22 July 2021.

Last reviewed 2021-07-22 · How we verify

NCT04640207

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment

Completed NA Last updated 22 July 2021

What this trial tests

NA trial testing Facial skin treatment in Rejuvenation in 22 participants. Completed in 18 July 2021.

Timeline

25 November 2020

Primary endpoint
18 July 2021

18 July 2021

Quick facts

Lead sponsor	Alma Lasers
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	25 November 2020
Primary completion	18 July 2021
Estimated completion	18 July 2021
Sites	1 location across United States

Drugs / interventions tested

Facial skin treatment

Conditions studied

Rejuvenation — all drugs for Rejuvenation →

Sponsor

Alma Lasers

Who can join

Adults 35 to 60, any sex, with Rejuvenation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is aimed to evaluate the efficacy of the Alma Hybrid system for a new approach of facial skin treatment, using both ablative and non-ablative wavelengths. The study will include 20 subjects with mild-moderate photodamaged skin, that will undergo 2 facial skin treatments. Follow up visit to evaluate the efficacy of the treatments will take place 1 and 3 months after the last treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Rejuvenation

Currently open trials in the same condition.

NCT07227883 — Secretome Treatment for Facial Rejuvenation · EARLY_PHASE1 · recruiting

Other Alma Lasers trials

Trials by the same sponsor.

NCT06102343 — Safety and Efficacy Investigation on the Effects of ClearSkin Non-ablative ER:Glass 1540nm Laser Module in the Treatment · NA · unknown
NCT05016674 — Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat · NA · withdrawn
NCT04599751 — The Trio Laser Module for Hair Removal Treatment · NA · completed
NCT04153071 — Unipolar Microplasma Radiofrequency Device: In-vivo Histologic Study · NA · withdrawn
NCT03800563 — Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04640207 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alma Lasers
Last refreshed: 22 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04640207.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing